On Jul 21, 2021 TMRW Life Sciences closed a Series C round and debt financing, raised in total $105,000,000 from 5AM Ventures, Anne Wojcicki, Casdin Capital, GV, Peter Thiel, Special Situations Life Sciences Innovation Fund, Susan Wojcicki, Transformation Capital, round led by Transformation Capital. Signature Bank increased their existing debt facility.
About the company: TMRW Life Sciences is located in New York, United States. The company is a life sciences technology startup providing an automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization (IVF).
Company website: www.tmrw.org